For your skin
An FDA-recognised skin protectant that helps soothe the feeling of itch, redness, and dryness on irritated skin. FDA recognised it as a Category I skin protectant in 2003, and 1% creams showed improvement over their base formula for dry, irritation-prone skin in controlled trials.
Want the science? Keep reading ↓Mechanism of action
Finely milled whole-oat flour rich in beta-glucans (humectant film-former), avenanthramides (NF-kB inhibitors with antipruritic effect), starches, and saponins; together they hydrate the stratum corneum, dampen pro-inflammatory cytokine release in keratinocytes, and normalise skin pH.
Why we tier this strong
5 cited papers across 1 country. Multiple positive efficacy results plus regulatory backing. Our catalog highlights 5 cited papers as direct references, a curated sample from the broader body of published research that earns Colloidal Oatmeal its Strong tier (15+ studies including multiple RCTs or a large longitudinal cohort). See our methodology for how we evaluate evidence.
Cited research
Lisante TA, Nuñez C, Berube D, Leyden J. A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in Black or African American children. J Dermatolog Treat. 2023;34(1):2241587. — randomized controlled trial; OTC 1% oatmeal cream at least as effective and safe as prescription barrier cream in this population.
Jones VA, Patel PM, Wilson C, Wang H, Ashack KA. Complementary and alternative medicine treatments for common skin diseases: A systematic review and meta-analysis. JAAD Int. 2021;2:76-93. — Systematic review and meta-analysis of 40 RCTs found qualitative evidence supporting colloidal oatmeal for atopic dermatitis; quantitative meta-analysis found no statistically significant difference vs placebo across CAM treatments.
Sobhan M, Hojati M, Vafaie SY, et al. Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis. J Drugs Dermatol. 2020;19(10):s4-s7.
Lisante TA, Nuñez C, Zhang P. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study. J Dermatolog Treat. 2017;28(7):659-667. — OTC 1% oatmeal cream non-inferior to prescription barrier cream across EASI, IGADA, and itch-severity scores.
Reynertson KA, Garay M, Nebus J, et al. Anti-inflammatory activities of colloidal oatmeal (Avena sativa) contribute to the effectiveness of oats in treatment of itch associated with dry, irritated skin. J Drugs Dermatol. 2015;14(1):43-48.
Sources: 10 clinical journals and regulatory databases across the US, EU, Korea, Japan, and China. Every entry points to a specific document. See methodology for the full list and what each outcome label means.